Grace Therapeutics, Inc. · NASDAQ:GRCE

Opaleye Management Inc. bought 14,632 Grace Therapeutics, Inc. shares (Form 4)

Traded Oct 8 to Oct 12, 2026 · Filed Oct 13, 2026

From Oct 8 to Oct 12, 2026, Opaleye Management Inc. (10% owner) bought 14,632 Grace Therapeutics, Inc. shares at an average US$2.03 for US$29,683, leaving 2,873,289 shares. Filed Oct 13, 2026 (Form 4).

Bought
14,632 shares
Price
US$2.03 average (US$2.02 to US$2.04)
Value
US$29,683
Holding after
2,873,289 shares (held indirectly)
Trading plan
No
Role
10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 8, 2026Common Stock, par value $0.0001 per shareBuy2,077US$2.022,860,734Indirect
Oct 9, 2026Common Stock, par value $0.0001 per shareBuy5,340US$2.042,866,074Indirect
Oct 12, 2026Common Stock, par value $0.0001 per shareBuy7,215US$2.022,873,289Indirect

Source

View original at SEC

Related